Part D/Prescription Drugs

DEA decision keeps major restrictions in place on marijuana research

(By Andrew Joseph for STAT)

Federal drug enforcement authorities announced Thursday that they would continue defining marijuana as a drug with a high potential for abuse and no accepted medical value, a decision that keeps in place significant restrictions on biomedical research. Continue reading article here…..

 

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.